Publications of Julita Piasecka

Rüdiger, D.; Piasecka, J.; Küchler, J.; Pontes, C.; Laske, T.; Kupke, S. Y.; Reichl, U.: Mathematical model calibrated to in vitro data predicts mechanisms of antiviral action of the influenza defective interfering particle “OP7”. iScience 27 (4), 109421 (2024)

Pelz, L.; Dogra, T.; Piasecka, J.; Rüdiger, D.; Bälkner, M.; Boehme, J.D.; Kershaw, O.; Volckmar, J.; Genzel, Y.; Bruder, D. et al.; Kupke, S. Y.; Reichl, U.: Influenza Vector-Based Defective Interfering Particles for Use as Broad-Spectrum Antiviral and Mucosal Live Vaccine: Construction, Production and in Vivo Efficacy. 34^th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)

Piasecka, J.; Rüdiger, D.; Küchler, J.; Kupke, S. Y.; Reichl, U.: Molecular basis for the antiviral activity of the influenza defective interfering particle “OP7”. 34^th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)

Rüdiger, D.; Piasecka, J.; Küchler, J.; Kupke, S. Y.; Reichl, U.: The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanisms. 34^th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)

Piasecka, J.; Rüdiger, D.; Küchler, J.; Kupke, S. Y.; Reichl, U.: Mechanisms of antiviral action of the influenza defective interfering particle “OP7”. 33^rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)

Piasecka, J.; Rüdiger, D.; Küchler, J.; Kupke, S. Y.; Reichl, U.: Mechanisms of antiviral action of the influenza defective interfering particle “OP7”. 28th ESACT Meeting, Edinburgh (Scotland) (2024)

Piasecka, J.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Reduced transcription of the mutated genomic segment 7 of the novel “OP7” influenza defective interfering particle intended for use as an antiviral. 8^th European Congress of Virology, Gdańsk (Poland) (2023)

Piasecka, J.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Promoter mutations in novel “OP7” influenza defective interfering particle severely reduce transcription of its genomic segment 7. 32^nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)

Piasecka, J.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviral. 17^th Vaccine Congress, Glasgow (Scotland) (2023)